New Generation Of Biological Prosthetic Heart Valves
Pioneer In Bioprosthetic Valve Technology
Shanghai "Thousand Talents Plan" Enterprise
Dedicated to the cause of patient health, striving to use new technology to improve public health and life quality
Patents for prosthetic heart valve inventions are licensed in China, Europe, the United States
Established in October 2010 by Dr. Jun Yang, a member of the ISO5840 Standard Committee, Cingular is a high-tech medical enterprise dedicated to the research, development, production and sales of high-end medical products for human health. The company has got the ENISO13485：2016 system certification for several years, and has built 2000 square meters of clean area, a combination of 100,000-grade and 10,000-grade, (with 100-grade built in), meets GMP requirements. Has fifteen invention patents (China, and International), the actual research and development spending is over 200 million RMB.
2000㎡
2000 square meters of clean area
15items
Invention patents (China, PCT & International)
200+million RMB
Actual research and development spending
Overcome Challenges effectively and precisely, Promote Medical Accessibility
We're committed to making biological heart valves available to more patients
Providing better health solutions for doctors in treating patients
